{"id":145696,"date":"2025-04-30T13:09:08","date_gmt":"2025-04-30T11:09:08","guid":{"rendered":"https:\/\/www.startupbusiness.it\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\/145696\/"},"modified":"2025-04-30T13:15:48","modified_gmt":"2025-04-30T11:15:48","slug":"eur-1-14-million-round-for-medtech-innovation-at-mgshell","status":"publish","type":"post","link":"https:\/\/www.startupbusiness.it\/en\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\/145696\/","title":{"rendered":"EUR 1.14 million round for medtech innovation at MgShell"},"content":{"rendered":"\n

MgShell, a medtech company specialising in the development of innovative technologies for the treatment of eye diseases, announces the closing of a EUR 1,140,000 investment round. The transaction is led by Capital Cell and Andrea Giani, <\/strong>with the participation of current investor partners, including members of the Investors Club through Simon Fiduciaria, Italian Angels for Biotech and Bios Line Holding.<\/p>\n\n

The funds will enable MgShell <\/a>to accelerate the development and pre-clinical validation of its innovative technology, support product development, advance business development activities and strengthen the team. MgShell will continue to work to complete the development of the technology, with the aim of bringing it to market as quickly as possible and offering an innovative solution to doctors and patients. <\/p>\n\n

“This investment represents a crucial step for MgShell, confirming the strength of our vision and the value of our technology. With the support of experienced and strategic investors, we are ready to accelerate our path towards clinical validation and market access. Our aim is to offer innovative and effective solutions for the treatment of eye diseases, significantly improving the quality of life of patients,’ says Marco Ferroni, CEO of MgShell, in a note.<\/strong><\/p>\n\n

Daniel Oliver, Director of Capital Cell, comments: ‘We are excited to support MgShell on its growth path.<\/strong> Their technology represents an innovative solution in an industry with a huge need for effective new therapies. We firmly believe in their potential and the team’s ability to turn this vision into reality.” <\/p>\n\n

Andrea Giani, investor and retinal specialist, adds: ‘I am convinced that MgShell can revolutionise retinal therapies, addressing a still unmet clinical need thanks to its innovative technology.<\/strong> Its approach could reach current standards of efficacy and safety, reducing the therapeutic burden for patients, caregivers and physicians. It is a pleasure to support MgShell with its deep expertise and impressive research and development programme led by Marco Ferroni and Francesco De Gaetano.” <\/p>\n\n

Enrico Gianotti, member of the Board and champion of the Investors Club, says: “This second round of investment represents a strong vote of confidence in MgShell and will play a crucial role in enabling the company to achieve its strategic goal of preclinical validation on schedule.<\/strong> While we recognise the importance and complexity of the steps still to be taken, we strongly believe that the strength, commitment and expertise of the team will be instrumental in bringing the project to a successful outcome.”<\/p>\n\n

Federica Girolami, investor and champion of Italian Angels for Biotech, says: “I believe MgShell has the potential to revolutionise the ophthalmic sector.<\/strong> By developing a medical device that directly addresses critical unmet retinal health needs, this initiative has the potential to significantly improve clinical outcomes and quality of life for patients”.<\/p>\n\n

“The Italian biotech sector needs companies like MgShell, capable of innovating and carrying out projects with a high scientific and clinical impact. We believe in the value of this technology and in the skills of the MgShell team to successfully reach the market responding to a clear and urgent need of patients,” says Lucio Rovati, investor and CEO of Rottapharm Biotech.<\/strong><\/p>\n\n

Paolo Tramonti, CEO of Bios Line Holding, adds: “After my experience with Next Sight, I recognised in MgShell the same potential for high-impact innovation in the ophthalmic field.<\/strong> Marco and his team demonstrated great executive capacity and a clear vision, which is why I decided to invest again.”<\/p>\n\n

‘From an investment and governance perspective, MgShell stands out for its sound management and ability to achieve key objectives. We have full confidence in the direction taken and the long-term value of the project,’ concludes Stefano Gallucci, advisor to Bios Line Holding.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

The start-up proposes innovations in the field of eye disease treatment, leads the Capital Cell round together with Andrea Giani<\/p>\n","protected":false},"author":125,"featured_media":145695,"comment_status":"open","ping_status":"open","sticky":true,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1317],"tags":[1143,1137,2016,1136],"companies":[2650],"journalist":[1518],"class_list":["post-145696","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-funding-news","tag-investments","tag-italy-en","tag-med-tech-en","tag-startup-en-2","companies-mgshell-en","journalist-editorial-staff-en"],"featured_sizes_urls":{"thumbnail":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/04\/Screenshot-2025-04-30-alle-13.07.22.webp","width":150,"height":105,"crop":false,"srcset":false,"alt":"patologie oculari"},"large":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/04\/Screenshot-2025-04-30-alle-13.07.22.webp","width":1024,"height":717,"crop":false,"srcset":false,"alt":"patologie oculari"},"2048x2048":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/04\/Screenshot-2025-04-30-alle-13.07.22.webp","width":1180,"height":826,"crop":false,"srcset":false,"alt":"patologie oculari"}},"acf":[],"yoast_head":"\nEUR 1.14 million round for medtech innovation at MgShell<\/title>\n<meta name=\"description\" content=\"The start-up proposes innovations in the field of eye disease treatment, leads the Capital Cell round together with Andrea Giani\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.startupbusiness.it\/en\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\/145696\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EUR 1.14 million round for medtech innovation at MgShell\" \/>\n<meta property=\"og:description\" content=\"The start-up proposes innovations in the field of eye disease treatment, leads the Capital Cell round together with Andrea Giani\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.startupbusiness.it\/en\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\/145696\/\" \/>\n<meta property=\"og:site_name\" content=\"Startupbusiness.it\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-30T11:09:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-30T11:15:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/04\/Screenshot-2025-04-30-alle-13.07.22.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"826\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Emil Abirascid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@emilabirascid\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Emil Abirascid\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\\\/145696\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\\\/145696\\\/\"},\"author\":{\"name\":\"Emil Abirascid\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\"},\"headline\":\"EUR 1.14 million round for medtech innovation at MgShell\",\"datePublished\":\"2025-04-30T11:09:08+00:00\",\"dateModified\":\"2025-04-30T11:15:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\\\/145696\\\/\"},\"wordCount\":607,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\\\/145696\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/Screenshot-2025-04-30-alle-13.07.22.webp\",\"keywords\":[\"investments\",\"italy\",\"med-tech\",\"startup\"],\"articleSection\":[\"Funding News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\\\/145696\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\\\/145696\\\/\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\\\/145696\\\/\",\"name\":\"EUR 1.14 million round for medtech innovation at MgShell\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\\\/145696\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\\\/145696\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/Screenshot-2025-04-30-alle-13.07.22.webp\",\"datePublished\":\"2025-04-30T11:09:08+00:00\",\"dateModified\":\"2025-04-30T11:15:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\"},\"description\":\"The start-up proposes innovations in the field of eye disease treatment, leads the Capital Cell round together with Andrea Giani\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\\\/145696\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\\\/145696\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/Screenshot-2025-04-30-alle-13.07.22.webp\",\"contentUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/Screenshot-2025-04-30-alle-13.07.22.webp\",\"width\":1180,\"height\":826,\"caption\":\"patologie oculari\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/\",\"name\":\"Startupbusiness.it\",\"description\":\"May the Force be with you!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\",\"name\":\"Emil Abirascid\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"caption\":\"Emil Abirascid\"},\"description\":\"Emil Abirascid (\u30a8\u30df\u30fc\u30eb\u30fb\u30a2\u30d3\u30e9\u30b7\u30c3\u30c9), giornalista, fondatore e direttore di Startupbusiness, il primo magazine sull\u2019ecosistema startup e innovazione italiano. Co-fondatore di Designtech, l\u2019hub di innovazione che avvicina il mondo del design con quello della tecnologia. Advisor di Austrian Business Agency, Emil Banca, Fondazione Symbola, Fondazione Quadrans. Partecipa regolarmente a incontri, convegni, conferenze dedicate all\u2019ecosistema dell\u2019innovazione. E\u2019 stato co-organizzatore degli Italian Innovation Day and Series che si sono svolti dal dal 2016 al 2020 nelle citt\u00e0 di Tokyo in Giappone, Melbourne, Adelaide, Perth, Canberra in Australia e Singapore e co-organizzatore dell\u2019Italy India Innovation Day di AIICP 2021 e 2022. Ha curato il volume \u2018L\u2019innovazione che non ti aspetti. Contesti e visioni per l\u2019impresa\u2019 , l\u2019edizione italiana di \u2018La startup digitale, guida pratica step by step\u2019 e ha scritto la prefazione all\u2019edizione italiana de \u2018La quarta era\u2019 di Byron Reese, ed \u00e8 co-autore di \u2018Cosa e Dove: strategie digitali di ricerca del lavoro\u2019, tutti editi da FrancoAngeli. In passato \u00e8 stato curatore di StartupDigest Italy, coordinatore scientifico del Forum per la Ricerca della Provincia Autonoma di Trento, board member di TechChill Milano advisor di di ScaleIT , ha collaborato con Il Sole 24 Ore \u00e8 stato direttore di Innov\u2019azione, bimestrale edito da Apsti, ha collaborato con Corriere Innovazione ed \u00e8 stato presidente del comitato di selezione del Premio Marzotto e advisor di Cetif-Universit\u00e0 Cattolica Milano.\",\"sameAs\":[\"https:\\\/\\\/www.abirascid.com\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/emilabirascid\",\"https:\\\/\\\/x.com\\\/emilabirascid\"],\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/author\\\/emil-abirascid\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EUR 1.14 million round for medtech innovation at MgShell","description":"The start-up proposes innovations in the field of eye disease treatment, leads the Capital Cell round together with Andrea Giani","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.startupbusiness.it\/en\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\/145696\/","og_locale":"en_US","og_type":"article","og_title":"EUR 1.14 million round for medtech innovation at MgShell","og_description":"The start-up proposes innovations in the field of eye disease treatment, leads the Capital Cell round together with Andrea Giani","og_url":"https:\/\/www.startupbusiness.it\/en\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\/145696\/","og_site_name":"Startupbusiness.it","article_published_time":"2025-04-30T11:09:08+00:00","article_modified_time":"2025-04-30T11:15:48+00:00","og_image":[{"width":1180,"height":826,"url":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/04\/Screenshot-2025-04-30-alle-13.07.22.webp","type":"image\/webp"}],"author":"Emil Abirascid","twitter_card":"summary_large_image","twitter_creator":"@emilabirascid","twitter_misc":{"Written by":"Emil Abirascid","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.startupbusiness.it\/en\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\/145696\/#article","isPartOf":{"@id":"https:\/\/www.startupbusiness.it\/en\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\/145696\/"},"author":{"name":"Emil Abirascid","@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd"},"headline":"EUR 1.14 million round for medtech innovation at MgShell","datePublished":"2025-04-30T11:09:08+00:00","dateModified":"2025-04-30T11:15:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.startupbusiness.it\/en\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\/145696\/"},"wordCount":607,"commentCount":0,"image":{"@id":"https:\/\/www.startupbusiness.it\/en\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\/145696\/#primaryimage"},"thumbnailUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/04\/Screenshot-2025-04-30-alle-13.07.22.webp","keywords":["investments","italy","med-tech","startup"],"articleSection":["Funding News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.startupbusiness.it\/en\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\/145696\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.startupbusiness.it\/en\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\/145696\/","url":"https:\/\/www.startupbusiness.it\/en\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\/145696\/","name":"EUR 1.14 million round for medtech innovation at MgShell","isPartOf":{"@id":"https:\/\/www.startupbusiness.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.startupbusiness.it\/en\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\/145696\/#primaryimage"},"image":{"@id":"https:\/\/www.startupbusiness.it\/en\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\/145696\/#primaryimage"},"thumbnailUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/04\/Screenshot-2025-04-30-alle-13.07.22.webp","datePublished":"2025-04-30T11:09:08+00:00","dateModified":"2025-04-30T11:15:48+00:00","author":{"@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd"},"description":"The start-up proposes innovations in the field of eye disease treatment, leads the Capital Cell round together with Andrea Giani","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.startupbusiness.it\/en\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\/145696\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.startupbusiness.it\/en\/eur-1-14-million-round-for-medtech-innovation-at-mgshell\/145696\/#primaryimage","url":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/04\/Screenshot-2025-04-30-alle-13.07.22.webp","contentUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/04\/Screenshot-2025-04-30-alle-13.07.22.webp","width":1180,"height":826,"caption":"patologie oculari"},{"@type":"WebSite","@id":"https:\/\/www.startupbusiness.it\/en\/#website","url":"https:\/\/www.startupbusiness.it\/en\/","name":"Startupbusiness.it","description":"May the Force be with you!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.startupbusiness.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd","name":"Emil Abirascid","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","caption":"Emil Abirascid"},"description":"Emil Abirascid (\u30a8\u30df\u30fc\u30eb\u30fb\u30a2\u30d3\u30e9\u30b7\u30c3\u30c9), giornalista, fondatore e direttore di Startupbusiness, il primo magazine sull\u2019ecosistema startup e innovazione italiano. Co-fondatore di Designtech, l\u2019hub di innovazione che avvicina il mondo del design con quello della tecnologia. Advisor di Austrian Business Agency, Emil Banca, Fondazione Symbola, Fondazione Quadrans. Partecipa regolarmente a incontri, convegni, conferenze dedicate all\u2019ecosistema dell\u2019innovazione. E\u2019 stato co-organizzatore degli Italian Innovation Day and Series che si sono svolti dal dal 2016 al 2020 nelle citt\u00e0 di Tokyo in Giappone, Melbourne, Adelaide, Perth, Canberra in Australia e Singapore e co-organizzatore dell\u2019Italy India Innovation Day di AIICP 2021 e 2022. Ha curato il volume \u2018L\u2019innovazione che non ti aspetti. Contesti e visioni per l\u2019impresa\u2019 , l\u2019edizione italiana di \u2018La startup digitale, guida pratica step by step\u2019 e ha scritto la prefazione all\u2019edizione italiana de \u2018La quarta era\u2019 di Byron Reese, ed \u00e8 co-autore di \u2018Cosa e Dove: strategie digitali di ricerca del lavoro\u2019, tutti editi da FrancoAngeli. In passato \u00e8 stato curatore di StartupDigest Italy, coordinatore scientifico del Forum per la Ricerca della Provincia Autonoma di Trento, board member di TechChill Milano advisor di di ScaleIT , ha collaborato con Il Sole 24 Ore \u00e8 stato direttore di Innov\u2019azione, bimestrale edito da Apsti, ha collaborato con Corriere Innovazione ed \u00e8 stato presidente del comitato di selezione del Premio Marzotto e advisor di Cetif-Universit\u00e0 Cattolica Milano.","sameAs":["https:\/\/www.abirascid.com\/","https:\/\/www.linkedin.com\/in\/emilabirascid","https:\/\/x.com\/emilabirascid"],"url":"https:\/\/www.startupbusiness.it\/en\/author\/emil-abirascid\/"}]}},"author_name":"Emil Abirascid","categories_names":["Funding News"],"_links":{"self":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/145696","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/comments?post=145696"}],"version-history":[{"count":1,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/145696\/revisions"}],"predecessor-version":[{"id":145697,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/145696\/revisions\/145697"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/media\/145695"}],"wp:attachment":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/media?parent=145696"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/categories?post=145696"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/tags?post=145696"},{"taxonomy":"companies","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/companies?post=145696"},{"taxonomy":"journalist","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/journalist?post=145696"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}